Heidi L. Weiss, PhD

  • Associate Director, Shared Resource Facilities
  • Director, Biostatistics Shared Resource Facility

About

Faculty Rank

  • Professor

Research

Research Focus

Design and analysis of early phase clinical trials focusing on Bayesian design and interim monitoring. Statistical analysis of transgenic, xenograft and chemically induced mouse models of cancer.

Contact Information

800 Rose Street
CC448 Roach Building, University of Kentucky
Lexington, KY 40536
United States

Phone

Publications

  1. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
    Massarweh S, Tham YL, Huang J, Sexton K, Weiss H, Tsimelzon A, Beyer A, Rimawi M, Cai WY, Hilsenbeck S, Fuqua S and Elledge R. Breast Cancer Res Treat 129:819-27, 2011.
  2. Bayesian Monitoring of a phase II chemoprevention trial in high risk cohorts for prostate cancer.
    Weiss HL, Urban DA, Grizzle WE, Cronin KA, Freedman LS, Kelloff GJ, Lieberman R. Urology 57(4A):220-223, 2001.